TrialFrontiers in immunology2021

Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial.

Lorna Leal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.